|
 |
|
|
| |
In the frame of the joint research project „Added value in regenerative medicine – a pioneering project for the reduction of translation obstacles“ RTC will develop novel methodologies for the demonstration of safety and for basic research regarding the functional principle of stem cells. In this context, RTC will coordinate the knowledge and technology-transfer. In collaboration with the  Patent & Valorisation Agency – Mecklenburg-Vorpommern AG patentable developments and processes, as well as brand names and samples will be protected by patents and placed on the market. |
|
| |
|
|
|
|
